Skip to content

Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis

Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02886936
Enrollment
71
Registered
2016-09-01
Start date
2018-05-01
Completion date
2022-05-31
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation

Keywords

transtibial, transfemoral

Brief summary

iFIT Prosthetics, LLC® created and commercialized a modular, immediate fit, fully adjustable, prosthetic system suitable for mass production using high strength injection molded polymer materials. The aim of this project is to assess the design, user satisfaction and feasibility of this device. The investigators will be fitting transtibial and transfemoral amputees with the iFIT prosthetic system. Patients will wear the device for 2 weeks in order to compare the device to their own prosthetic (if they currently have one). They will report any device breakages or adverse events. They will also fill out a questionnaire to determine if the iFIT prosthetic is a feasible option for treating patients with limb loss.

Interventions

DEVICEiFIT Transtibial Prosthesis

Transtibial amputee volunteers will be fit with the iFIT device and instructed on its use. Patient will wear the iFIT device for a two week time period according to a provided wear schedule. At the end of this time patient will rate it for comfort, stability and ease of use.

DEVICEiFIT Transfemoral Prosthesis

Transfemoral amputee volunteers will be fit with the iFIT device and instructed on its use. Patient will wear the iFIT device for a two week time period according to a provided wear schedule. At the end of this time patient will rate it for comfort, stability and ease of use.

Sponsors

iFIT Prosthetics, LLC
CollaboratorINDUSTRY
National Institute on Aging (NIA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

single-group pre-post intervention study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* transtibial or transfemoral level of amputation * functional ambulator with or without a cane * six months or more since amputation.

Exclusion criteria

* patient have skin ulcerations on the residual limb * have other central nervous system disorders such as strokes and brain injuries that interfere with safe ambulation and gait testing * severe phantom or limb pain * weight over 260 lbs

Design outcomes

Primary

MeasureTime frameDescription
Prosthetic Comfort and Utility Questionnaire (Version 1)2 weeksThis questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version featured seven questions for a total of 35 points possible and the lowest score being 7 (higher scores are better). Scores are reported as total with standard deviations.
Prosthetic Comfort and Utility Questionnaire (Version 2)2 weeksThis questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version features fourteen questions for a total of 70 points total, with the lowest score being 14. Higher scores are better. Scores are reported as total with standard deviations.
Prosthetic Comfort and Utility Evaluation (Version 3)2 weeksThis questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version features ten questions for a total of 50 points possible, with the lowest score being 10. Higher scores are better. Scores are reported as total with standard deviations.

Secondary

MeasureTime frameDescription
Gait Analysis - Double Support2 weeksDouble support is the amount of time that both feet are touching the ground during walking. A faster gait will correlate with lower values since less time is spent with both feet on the ground; consequently, a slower gait will yield higher values.
Gait Analysis - Limp Index2 weeksLimp index is a temporal parameter used in gait analysis to describe symmetry when walking. For a symmetric walk, the limp index is exactly one; values significantly higher or lower than 1 denote greater asymmetry. It is calculated by using the total support (single + double) for the current foot divided by the total support for the opposite foot.
Number of Participants With Device Related Adverse Events2 weeksWe will record any unfavorable events such that occur including: skin irritation, skin breakdown, falls, or mechanical failures.
Gait Analysis Stance Phase2 weeksBegins when the foot first touches the ground and ends when the same foot leaves the ground. Expressed as a percentage of the total gait cycle.
Residual Limb Circumference Measurements to Internal Socket DiameterSame DayThe subject's residual limb was measured at the proximal 1/3, midpoint and distal 1/3 while wearing their liner and on skin. This was compared to their internal socket circumference.
Gait Analysis - Stride Length2 weeksStride length is the distance between successive points of initial contact of the same foot. Right and left stride lengths are normally equal.
Gait Analysis- Walking Speedtwo weeksGait speed is the time one takes to walk a specified distance on level surfaces over a short distance.
Internal Socket PressureTwo weeksFujifilm prescale was placed on five specific places on the outside of the participant's liner. They then ambulated for two minutes. The paper was removed and average pressure was recorded. This was completed for both sockets.

Countries

United States

Participant flow

Participants by arm

ArmCount
Transtibial Testing Study 1
This is a feasibility and effectiveness study to assess the iFIT transtibial prosthesis as a viable alternative to a traditional prosthesis. We also hope to gain information that will influence future design iterations. iFIT Transtibial Prosthesis: Transtibial amputee volunteers will be fit with the iFIT device and instructed on its use. Patient will wear the iFIT device for a two week time period according to a provided wear schedule. At the end of this time patient will rate it for comfort, stability and ease of use.
26
Transtibial Testing Study 2
This is a follow up feasibility and effectiveness study to assess the iFIT transtibial prosthesis as a viable alternative to a traditional prosthesis. We also hope to gain information that will influence future design iterations. iFIT Transtibial Prosthesis: Transtibial amputee volunteers will be fit with the iFIT device and instructed on its use. Patient will wear the iFIT device for a two week time period according to a provided wear schedule. At the end of this time patient will rate it for comfort, stability and ease of use.
27
Transfemoral Testing
This is a feasibility and effectiveness study to assess the iFIT transfemoral prosthesis as a viable alternative to a traditional prosthesis. We also hope to gain information that will influence future design iterations. iFIT Transfemoral Prosthesis: Transfemoral amputee volunteers will be fit with the iFIT device and instructed on its use. Patient will wear the iFIT device for a two week time period according to a provided wear schedule. At the end of this time patient will rate it for comfort, stability and ease of use.
18
Total71

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up430

Baseline characteristics

CharacteristicTranstibial Testing Study 1Transtibial Testing Study 2Transfemoral TestingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants6 Participants6 Participants16 Participants
Age, Categorical
Between 18 and 65 years
22 Participants21 Participants12 Participants55 Participants
Age, Continuous50 years
STANDARD_DEVIATION 10.2
55 years
STANDARD_DEVIATION 13.2
59.4 years
STANDARD_DEVIATION 7
54.8 years
STANDARD_DEVIATION 10.1
Race/Ethnicity, Customized
Race/Ethnicity
African American/Black
14 Participants13 Participants6 Participants33 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian/ Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic/ Latino
0 Participants3 Participants2 Participants5 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
0 Participants0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White/ not Hispanic
12 Participants11 Participants10 Participants33 Participants
Region of Enrollment
United States
26 Participants27 Participants18 Participants71 Participants
Sex: Female, Male
Female
4 Participants5 Participants2 Participants11 Participants
Sex: Female, Male
Male
22 Participants22 Participants16 Participants60 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 260 / 270 / 18
other
Total, other adverse events
2 / 260 / 270 / 18
serious
Total, serious adverse events
0 / 260 / 270 / 18

Outcome results

Primary

Prosthetic Comfort and Utility Evaluation (Version 3)

This questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version features ten questions for a total of 50 points possible, with the lowest score being 10. Higher scores are better. Scores are reported as total with standard deviations.

Time frame: 2 weeks

Population: Participants with transfemoral limb loss that completed the two week follow up.

ArmMeasureGroupValue (MEAN)Dispersion
Transtibial Testing Study 1Prosthetic Comfort and Utility Evaluation (Version 3)iFIT Prosthesis40.9 score on a scaleStandard Deviation 7.2
Transtibial Testing Study 1Prosthetic Comfort and Utility Evaluation (Version 3)Conventional Prosthesis32.8 score on a scaleStandard Deviation 10.2
Primary

Prosthetic Comfort and Utility Questionnaire (Version 1)

This questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version featured seven questions for a total of 35 points possible and the lowest score being 7 (higher scores are better). Scores are reported as total with standard deviations.

Time frame: 2 weeks

Population: Persons completing the two week trial from the first cohort.

ArmMeasureGroupValue (MEAN)Dispersion
Transtibial Testing Study 1Prosthetic Comfort and Utility Questionnaire (Version 1)Conventional Prosthesis25.52 score on a scaleStandard Deviation 6.8
Transtibial Testing Study 1Prosthetic Comfort and Utility Questionnaire (Version 1)iFIT Prosthesis29.33 score on a scaleStandard Deviation 4.51
Primary

Prosthetic Comfort and Utility Questionnaire (Version 2)

This questionnaire is based off of the Prosthetic Evaluation Questionnaire; it involves questions taken from the original that focus on comfort, satisfaction and utility of a prosthetic socket. We used numeric values from 1 (Poor) through 5 (Excellent) for evaluation. This version features fourteen questions for a total of 70 points total, with the lowest score being 14. Higher scores are better. Scores are reported as total with standard deviations.

Time frame: 2 weeks

Population: Transtibial participants that returned for 2 week follow up in the second cohort of subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Transtibial Testing Study 1Prosthetic Comfort and Utility Questionnaire (Version 2)iFIT Prosthesis29 score on a scaleStandard Deviation 4.5
Transtibial Testing Study 1Prosthetic Comfort and Utility Questionnaire (Version 2)Conventional Prosthesis25.4 score on a scaleStandard Deviation 6.8
Secondary

Gait Analysis - Double Support

Double support is the amount of time that both feet are touching the ground during walking. A faster gait will correlate with lower values since less time is spent with both feet on the ground; consequently, a slower gait will yield higher values.

Time frame: 2 weeks

Population: Persons from the first cohort (transtibial testing study 1) that completed the two week trial and had unilateral amputation. Cohort two was not tested. Persons with transfemoral amputation were not tested due to a difference in knees between testing conditions.

ArmMeasureGroupValue (MEAN)
Transtibial Testing Study 1Gait Analysis - Double SupportDouble Support Prosthetic Side- iFIT.37 seconds
Transtibial Testing Study 1Gait Analysis - Double SupportDouble Support Prosthetic Side - Conventional.36 seconds
Transtibial Testing Study 1Gait Analysis - Double SupportDouble Support Sound Side- iFIT.37 seconds
Transtibial Testing Study 1Gait Analysis - Double SupportDouble Support Sound Side- Conventional.35 seconds
Secondary

Gait Analysis - Limp Index

Limp index is a temporal parameter used in gait analysis to describe symmetry when walking. For a symmetric walk, the limp index is exactly one; values significantly higher or lower than 1 denote greater asymmetry. It is calculated by using the total support (single + double) for the current foot divided by the total support for the opposite foot.

Time frame: 2 weeks

Population: Participants from the first cohort (transtibial testing study 1) that completed the two week trial and had unilateral amputation. Persons in cohort two were not tested. Persons for the transfemoral testing were not tested as the componentry (prosthetic knees) were markedly different.

ArmMeasureGroupValue (MEAN)
Transtibial Testing Study 1Gait Analysis - Limp IndexLimp Index Prosthetic Side - iFIT.99 Index
Transtibial Testing Study 1Gait Analysis - Limp IndexLimp Index Sound Side- iFIT1.01 Index
Transtibial Testing Study 1Gait Analysis - Limp IndexLimp Index Prosthetic Side- Conventional.97 Index
Transtibial Testing Study 1Gait Analysis - Limp IndexLimp Index Sound Side - Conventional1.03 Index
Secondary

Gait Analysis Stance Phase

Begins when the foot first touches the ground and ends when the same foot leaves the ground. Expressed as a percentage of the total gait cycle.

Time frame: 2 weeks

Population: Persons from the first cohort (transtibial testing study 1) that completed the two week trial and had unilateral amputation. Cohort two was not tested. Persons with transfemoral amputation were not tested due to a difference in knees between testing conditions.

ArmMeasureGroupValue (NUMBER)
Transtibial Testing Study 1Gait Analysis Stance PhaseStance Phase- Prosthetic Side iFIT Avg64.3 Percentage of gait cycle
Transtibial Testing Study 1Gait Analysis Stance PhaseStance Phase- Prosthetic Side Conventional Avg63.4 Percentage of gait cycle
Transtibial Testing Study 1Gait Analysis Stance PhaseStance Phase- Sound Side iFIT Avg65.2 Percentage of gait cycle
Transtibial Testing Study 1Gait Analysis Stance PhaseStance Phase - Sound Side Conventional Avg65 Percentage of gait cycle
Secondary

Gait Analysis - Stride Length

Stride length is the distance between successive points of initial contact of the same foot. Right and left stride lengths are normally equal.

Time frame: 2 weeks

Population: Persons from the first cohort (transtibial testing study 1) that completed the two week trial and had unilateral amputation. Cohort two was not tested. Persons with transfemoral amputation were not tested due to a difference in knees between testing conditions.

ArmMeasureGroupValue (MEAN)
Transtibial Testing Study 1Gait Analysis - Stride LengthStride Length Prosthetic Side - iFIT1.22 meters
Transtibial Testing Study 1Gait Analysis - Stride LengthStride Length Prosthetic Side - Conventional1.22 meters
Transtibial Testing Study 1Gait Analysis - Stride LengthStride Length Sound Side - iFIT1.22 meters
Transtibial Testing Study 1Gait Analysis - Stride LengthStride Length Sounds Side - Conventional1.21 meters
Secondary

Gait Analysis- Walking Speed

Gait speed is the time one takes to walk a specified distance on level surfaces over a short distance.

Time frame: two weeks

Population: Persons from the first cohort (transtibial testing study 1) that completed the two week trial and had unilateral amputation. Cohort two was not tested. Persons with transfemoral amputation were not tested due to a difference in knees between testing conditions.

ArmMeasureGroupValue (MEAN)
Transtibial Testing Study 1Gait Analysis- Walking SpeedWalking Speed Sound Side- iFIT.98 m/s
Transtibial Testing Study 1Gait Analysis- Walking SpeedWalking Speed Prosthetic Side - iFIT.98 m/s
Transtibial Testing Study 1Gait Analysis- Walking SpeedWalking Speed Prosthetic Side - Conventional.98 m/s
Transtibial Testing Study 1Gait Analysis- Walking SpeedWalking Speed Sound Side - Conventional.98 m/s
Secondary

Internal Socket Pressure

Fujifilm prescale was placed on five specific places on the outside of the participant's liner. They then ambulated for two minutes. The paper was removed and average pressure was recorded. This was completed for both sockets.

Time frame: Two weeks

Population: This was completed on the first cohort for transtibial testing study 1. Testing was not completed on the second cohort or the transfemoral cohort.

ArmMeasureGroupValue (MEAN)Dispersion
Transtibial Testing Study 1Internal Socket PressureiFIT Overall Avg Pressure17.3 p/siStandard Deviation 2.3
Transtibial Testing Study 1Internal Socket PressureConventional Overall Avg Pressure19.3 p/siStandard Deviation 3.7
Transtibial Testing Study 1Internal Socket PressureiFIT Tibial Avg Pressure18 p/siStandard Deviation 4.2
Transtibial Testing Study 1Internal Socket PressureConventional Tibial Avg Pressure22 p/siStandard Deviation 3.7
Transtibial Testing Study 1Internal Socket PressureiFIT Medial Avg Pressure15.5 p/siStandard Deviation 2.6
Transtibial Testing Study 1Internal Socket PressureConventional Medial Avg Pressure16.3 p/siStandard Deviation 5.5
Transtibial Testing Study 1Internal Socket PressureiFIT Posterior Avg Pressure16.5 p/siStandard Deviation 3.6
Transtibial Testing Study 1Internal Socket PressureConventional Posterior Avg Pressure18.1 p/siStandard Deviation 7.5
Transtibial Testing Study 1Internal Socket PressureiFIT Bottom Avg Pressure20 p/siStandard Deviation 3.5
Transtibial Testing Study 1Internal Socket PressureConventional Bottom Avg Pressure20.5 p/siStandard Deviation 4.1
Transtibial Testing Study 1Internal Socket PressureiFIT Lateral Avg Pressure16.5 p/siStandard Deviation 4.8
Transtibial Testing Study 1Internal Socket PressureConventional Lateral Avg Pressure19.3 p/siStandard Deviation 4.9
Secondary

Number of Participants With Device Related Adverse Events

We will record any unfavorable events such that occur including: skin irritation, skin breakdown, falls, or mechanical failures.

Time frame: 2 weeks

Population: Participant completing the study

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Transtibial Testing Study 1Number of Participants With Device Related Adverse EventsMinor adverse event: skin irritation or minor skin breakdown2 Participants
Transtibial Testing Study 1Number of Participants With Device Related Adverse EventsSerious adverse event: Fall, device breakage, limb ischemia0 Participants
Transtibial Testing Study 1Number of Participants With Device Related Adverse EventsNO Adverse Events20 Participants
Transtibial Testing Study 2 (Follow Up)Number of Participants With Device Related Adverse EventsMinor adverse event: skin irritation or minor skin breakdown0 Participants
Transtibial Testing Study 2 (Follow Up)Number of Participants With Device Related Adverse EventsSerious adverse event: Fall, device breakage, limb ischemia0 Participants
Transtibial Testing Study 2 (Follow Up)Number of Participants With Device Related Adverse EventsNO Adverse Events24 Participants
Transfemoral TestingNumber of Participants With Device Related Adverse EventsSerious adverse event: Fall, device breakage, limb ischemia0 Participants
Transfemoral TestingNumber of Participants With Device Related Adverse EventsNO Adverse Events18 Participants
Transfemoral TestingNumber of Participants With Device Related Adverse EventsMinor adverse event: skin irritation or minor skin breakdown0 Participants
Secondary

Residual Limb Circumference Measurements to Internal Socket Diameter

The subject's residual limb was measured at the proximal 1/3, midpoint and distal 1/3 while wearing their liner and on skin. This was compared to their internal socket circumference.

Time frame: Same Day

Population: Only the transfemoral subjects were analyzed. This outcome measure was added after the transtibial subjects were tested.

ArmMeasureGroupValue (MEAN)Dispersion
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference No Liner Proximal 1/351.7 cmStandard Deviation 7.2
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference No Liner Mid Point47.2 cmStandard Deviation 7.7
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference No Liner Distal 1/340.6 cmStandard Deviation 7
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference WITH Liner Proximal 1/353.6 cmStandard Deviation 7.2
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference WITH Liner Mid Point47.7 cmStandard Deviation 6.1
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Circumference WITH Liner Distal 1/341.3 cmStandard Deviation 5.9
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Internal Socket Circumference Proximal 1/346.3 cmStandard Deviation 5.3
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Internal Socket Circumference Mid Point40.5 cmStandard Deviation 4.9
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Internal Socket Circumference Distal 1/335.7 cmStandard Deviation 5.6
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Difference Between Limb and Socket While Wearing Liner Proximal 1/37.3 cmStandard Deviation 3.6
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Difference Between Limb and Socket While Wearing Liner Mid Point7.2 cmStandard Deviation 3.9
Transtibial Testing Study 1Residual Limb Circumference Measurements to Internal Socket DiameterAvg Difference Between Limb and Socket While Wearing Liner Distal 1/35.6 cmStandard Deviation 4.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026